The KINECT-PRO™ analysis is the first and only of its kind to report both remission of tardive dyskinesia symptoms and associated improvements in patient-reported outcomes. Post-hoc analysis from ...

Neurocrine (NBIX) announced new data from a post-hoc analysis of the Phase 4 KINECT-PRO open-label study confirming that robust rates of symptomatic remission of tardive dyskinesia were achieved with ...

A new study reveals the subtle effects of survey interfaces on people's responses—and how those small differences can add up.

Restless nights can take a toll that goes beyond next-day tiredness. Sleep influences nearly every aspect of our health, and ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

There are many things known and unknown about the fascinating world of sleep. How the mind and body work silently towards repair and rejuvenation is still being understood with the help of ongoing ...

The president wants to enforce involuntary commitment laws for severe drug use. But rehab is expensive, without enough beds for those who seek it. By Jan Hoffman The sight is increasingly common: ...

Days after US President Donald Trump sounded off the alarm against pregnant women using paracetamol or acetaminophen (in the US – Tylenol and similar products), a report alleged that its maker was ...

President Donald Trump has been claiming that the ABC suspended late night host Jimmy Kimmel because of poor ratings, but he shared a different thought on Thursday about what the future of network ...

University of Michigan researchers have developed a tool powered by artificial intelligence that can help them examine the ...

As someone who writes about the AI industry relatively frequently for this site, there is one question that I find myself constantly asking and being asked in turn, in some form or another: What do ...

Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed. A one-time gene therapy can markedly slow the progression of Huntington’s ...